Pulmonary Sarcoidosis: Imaging and Diagnostic Limitations
RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren · 01.06.2026 · 198 (06) · 746-757
DOI: 10.1055/a-2722-6934 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, erschienen am 01.06.2026. Verfasst von Joana Kostova und 2 weiteren Autor:innen. Beteiligte Einrichtung: Cantonal Hospital Frauenfeld, Department of Radiology, Switzerland, Frauenfeld. Hauptthemen laut MEDLINE: Sarcoidosis, Pulmonary. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben.
Abstract (Originalsprache)
Pulmonary sarcoidosis is a multisystemic granulomatous disease with a broad spectrum of pulmonary manifestations, ranging from reversible hilar lymphadenopathy and perilymphatic nodules to irreversible pulmonary fibrosis. The heterogeneity complicates clinical and radiological differentiation. This review presents the typical radiological patterns of pulmonary sarcoidosis, evaluates diagnostic modalities, and highlights the importance for prognosis and therapy of distinguishing between reversible and irreversible lesions. A comprehensive literature search focused on recent publications and guidelines, emphasizing imaging techniques and clinically relevant correlations. Conventional chest radiography using Scadding criteria provides a simple and cost-effective method of stage classification, but it also has limitations in terms of accuracy and in correlation with lung function. Computed tomography (CT) is the most precise imaging modality, showing characteristic features such as symmetrical hilar and mediastinal lymphadenopathy, multiple micro- and macronodules with confluent consolidations, and upper lobe predominance. Advanced stages reveal fibrotic remodeling with linear opacities, traction bronchiectasis, and prognostically relevant honeycombing. Complications include pulmonary hypertension, venous compressions, and secondary fungal infections. Magnetic resonance imaging (MRI) is used primarily for cardiac sarcoidosis detection, while positron emission tomography (PET) can better assess inflammatory activity and therapy monitoring. Differential diagnosis with regard to other granulomatous, infectious, and neoplastic diseases is essential, and it requires an interdisciplinary approach. Pulmonary sarcoidosis requires a multimodal diagnostic approach, with CT playing a central role in staging and prognosis. Differentiation between reversible and fibrotic lesions is critical for therapeutic decisions. Future research should optimize imaging and integrate clinical, radiological, and functional parameters to improve patient care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Cantonal Hospital Frauenfeld, Department of Radiology, Switzerland, Frauenfeld.
- University Hospital Zurich, Department of Radiology, ZH, Switzerland, Zürich.
ORCID-Profile: Joana Kostova
Zitieren
APA
Kostova, J., Andreisek, G., & Müller, M. A. (2026). Pulmonary Sarcoidosis: Imaging and Diagnostic Limitations. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, 198(06), 746-757. https://doi.org/10.1055/a-2722-6934
Vancouver
Kostova J, Andreisek G, Müller MA. Pulmonary Sarcoidosis: Imaging and Diagnostic Limitations. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 2026;198(06):746-757. doi:10.1055/a-2722-6934
BibTeX
@article{Kostova2026,
author = {Kostova, Joana and Andreisek, Gustav and Müller, Mathias Andreas},
title = {Pulmonary Sarcoidosis: Imaging and Diagnostic Limitations},
journal = {RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren},
year = {2026},
volume = {198},
number = {06},
pages = {746--757},
doi = {10.1055/a-2722-6934}
}
EUVIMED